Clinical scientist led clinic in adult congenital heart disease - how to do it?
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Implementing an Adult Congenital Heart Disease (ACHD) Scientist-led clinic significantly reduced overdue appointments and costs. This innovative model enhances patient care accessibility, efficiency, and sustainability in ACHD services.
Area Of Science
- Cardiology
- Healthcare Management
- Clinical Science
Background
- Rising demand for Adult Congenital Heart Disease (ACHD) services necessitates improved efficiency and patient care.
- Traditional ACHD service models face challenges with patient backlogs and administrative coordination.
Purpose Of The Study
- To implement and evaluate an Adult Congenital Heart Disease (ACHD) Scientist-led clinic.
- To assess the impact of this model on waiting times, efficiency, cost-effectiveness, and patient satisfaction.
Main Methods
- A comprehensive service audit was conducted to identify challenges.
- Restructuring included an expanded appointment system, improved referral pathways, and enhanced clinical governance.
- Comparative cost analysis and patient satisfaction surveys were performed.
Main Results
- Overdue appointments reduced from 15% to 2%, despite increased patient numbers.
- The Clinical Scientist-led model proved more cost-effective than traditional approaches.
- Patient satisfaction and Consultant evaluations indicated high quality and safety.
Conclusions
- Clinical Scientist-led clinics offer a viable, cost-effective, and efficient alternative for ACHD care.
- This model has the potential to improve accessibility, efficiency, and sustainability within ACHD networks.
- Broader adoption of this model can optimize patient outcomes and resource utilization.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...